Difference between revisions of "Document Archive"
Jump to navigation
Jump to search
m |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | ''Public Comment closed'' | ||
| + | *[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | QIBA Profile: Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016]] | ||
| + | *[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|QIBA Profile Checklist: SPECT Profile Conformance]] | ||
| + | |||
| + | |||
| + | ''Public Comment closed'' | ||
| + | *[[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_v5-2-16b.docx|QIBA Profile: QIBA Profile: Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening, June 1, 2016]] | ||
| + | |||
| + | *[[Media:QIBA Small Nodule Profile References - Accuracy.xlsx|QIBA Spreadsheet: Small Nodule Profile References_Accuracy. Version for Public Comment. June 1, 2016]] | ||
| + | |||
| + | *[[Media:QIBA Small Nodule Profile References - Precision.xlsx|QIBA Spreadsheet: Small Nodule Profile References_Precision. Version for Public Comment. June 1, 2016]] | ||
| + | |||
*[[Media:QIBA FDG-PET Profile v103 rev 09Mar2013-PK wFDG-TC-Roster.pdf|QIBA Profile: <big><font color=red> FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy. v1.03. Version for Public Comment. March 9, 2013 </font></big>]] ''Public Comment period has ended for this Profile on May 24, 2013'' | *[[Media:QIBA FDG-PET Profile v103 rev 09Mar2013-PK wFDG-TC-Roster.pdf|QIBA Profile: <big><font color=red> FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy. v1.03. Version for Public Comment. March 9, 2013 </font></big>]] ''Public Comment period has ended for this Profile on May 24, 2013'' | ||
| Line 10: | Line 22: | ||
*[[Media:2011 07 28 Profile CT Advanced Disease V2 0f.pdf|Profile: <big><font color=red> QIBA Profile. Computed Tomography: Change Measurements in the Volumes of Solid Tumors </font></big>]] | *[[Media:2011 07 28 Profile CT Advanced Disease V2 0f.pdf|Profile: <big><font color=red> QIBA Profile. Computed Tomography: Change Measurements in the Volumes of Solid Tumors </font></big>]] | ||
*[[Media:2011 07 28 QIBA Proffered UPICT Protocol-Vol Measurements in Solid Tumors.pdf|Protocol: <big><font color=red> QIBA Proffered Protocol to UPICT. CT: Change Measurements in the Volumes of Solid Tumors </font></big>]] | *[[Media:2011 07 28 QIBA Proffered UPICT Protocol-Vol Measurements in Solid Tumors.pdf|Protocol: <big><font color=red> QIBA Proffered Protocol to UPICT. CT: Change Measurements in the Volumes of Solid Tumors </font></big>]] | ||
| + | |||
| + | |||
| + | *[[Media:QIBA-UPICT Oncologic FDG-PETCT Protocol v1.0 Version for Public Comment 6-7-13.pdf|QIBA-UPICT Proffered Protocol: <big><font color=red> FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy. v1.0. June 7, 2013</font></big>]] ''Public Comment Period has ended for this Profile on November 15, 2013'' | ||
| + | |||
| + | |||
| + | *[[Media:QIBA FDG-PET Profile v103 rev 09Mar2013-PK wFDG-TC-Roster.pdf|QIBA Profile: <big><font color=red> FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy. v1.03. Version for Public Comment. March 9, 2013 </font></big>]] ''Public Comment period has ended for this Profile on May 24, 2013'' | ||
Latest revision as of 22:43, 23 June 2017
Public Comment closed
- QIBA Profile: Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016
- QIBA Profile Checklist: SPECT Profile Conformance
Public Comment closed
- QIBA Spreadsheet: Small Nodule Profile References_Accuracy. Version for Public Comment. June 1, 2016
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy. v1.03. Version for Public Comment. March 9, 2013 Public Comment period has ended for this Profile on May 24, 2013
- Profile: DCE-MRI Quantification Version 1.6 12-13-2011
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy. v1.02. Version for Public Comment. January 11, 2013 Public Comment period ends on February 15, 2013
- Profile: QIBA Profile. Computed Tomography: Change Measurements in the Volumes of Solid Tumors
- Protocol: QIBA Proffered Protocol to UPICT. CT: Change Measurements in the Volumes of Solid Tumors
- QIBA-UPICT Proffered Protocol: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy. v1.0. June 7, 2013 Public Comment Period has ended for this Profile on November 15, 2013
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy. v1.03. Version for Public Comment. March 9, 2013 Public Comment period has ended for this Profile on May 24, 2013